Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

USA - NASDAQ:SRAD - CH1134239669 - Common Stock

29.375 USD
+0.45 (+1.54%)
Last: 9/18/2025, 2:18:53 PM
Fundamental Rating

6

Overall SRAD gets a fundamental rating of 6 out of 10. We evaluated SRAD against 133 industry peers in the Hotels, Restaurants & Leisure industry. While SRAD has a great health rating, its profitability is only average at the moment. SRAD is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make SRAD suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

SRAD had positive earnings in the past year.
SRAD had a positive operating cash flow in the past year.
In the past 5 years SRAD has always been profitable.
Each year in the past 5 years SRAD had a positive operating cash flow.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

With a decent Return On Assets value of 4.61%, SRAD is doing good in the industry, outperforming 64.66% of the companies in the same industry.
SRAD has a Return On Equity of 11.52%. This is in the better half of the industry: SRAD outperforms 67.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.66%, SRAD is in line with its industry, outperforming 48.87% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SRAD is significantly below the industry average of 15.68%.
The last Return On Invested Capital (4.66%) for SRAD is above the 3 year average (3.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.61%
ROE 11.52%
ROIC 4.66%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

The Profit Margin of SRAD (9.20%) is better than 71.43% of its industry peers.
SRAD's Profit Margin has been stable in the last couple of years.
SRAD has a Operating Margin (10.53%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SRAD has remained more or less at the same level.
SRAD has a better Gross Margin (73.35%) than 88.72% of its industry peers.
SRAD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.53%
PM (TTM) 9.2%
GM 73.35%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SRAD is destroying value.
Compared to 1 year ago, SRAD has more shares outstanding
Compared to 5 years ago, SRAD has more shares outstanding
SRAD has a better debt/assets ratio than last year.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

SRAD has an Altman-Z score of 3.99. This indicates that SRAD is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.99, SRAD belongs to the top of the industry, outperforming 81.20% of the companies in the same industry.
The Debt to FCF ratio of SRAD is 0.35, which is an excellent value as it means it would take SRAD, only 0.35 years of fcf income to pay off all of its debts.
SRAD's Debt to FCF ratio of 0.35 is amongst the best of the industry. SRAD outperforms 92.48% of its industry peers.
SRAD has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
SRAD's Debt to Equity ratio of 0.04 is amongst the best of the industry. SRAD outperforms 83.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 3.99
ROIC/WACC0.83
WACC5.63%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

SRAD has a Current Ratio of 1.31. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
SRAD has a Current ratio of 1.31. This is in the better half of the industry: SRAD outperforms 65.41% of its industry peers.
SRAD has a Quick Ratio of 1.31. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.31, SRAD is doing good in the industry, outperforming 67.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

9

3. Growth

3.1 Past

SRAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 230.77%, which is quite impressive.
SRAD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.84% yearly.
Looking at the last year, SRAD shows a quite strong growth in Revenue. The Revenue has grown by 19.38% in the last year.
Measured over the past years, SRAD shows a very strong growth in Revenue. The Revenue has been growing by 23.81% on average per year.
EPS 1Y (TTM)230.77%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%3306.25%
Revenue 1Y (TTM)19.38%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%14.14%

3.2 Future

The Earnings Per Share is expected to grow by 66.45% on average over the next years. This is a very strong growth
Based on estimates for the next years, SRAD will show a quite strong growth in Revenue. The Revenue will grow by 14.63% on average per year.
EPS Next Y282.53%
EPS Next 2Y106.68%
EPS Next 3Y80.58%
EPS Next 5Y66.45%
Revenue Next Year18.21%
Revenue Next 2Y17.56%
Revenue Next 3Y16.74%
Revenue Next 5Y14.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

SRAD is valuated quite expensively with a Price/Earnings ratio of 57.60.
SRAD's Price/Earnings is on the same level as the industry average.
SRAD's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 52.81, which means the current valuation is very expensive for SRAD.
Based on the Price/Forward Earnings ratio, SRAD is valued a bit more expensive than 63.16% of the companies in the same industry.
SRAD's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.70.
Industry RankSector Rank
PE 57.6
Fwd PE 52.81
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

SRAD's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRAD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 49.54
EV/EBITDA 16.26
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

SRAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SRAD may justify a higher PE ratio.
SRAD's earnings are expected to grow with 80.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)2.64
EPS Next 2Y106.68%
EPS Next 3Y80.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SRAD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (9/18/2025, 2:18:53 PM)

29.375

+0.45 (+1.54%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)N/A N/A
Inst Owners78.35%
Inst Owner Change5.44%
Ins Owners1.34%
Ins Owner ChangeN/A
Market Cap8.78B
Analysts81.6
Price Target33.77 (14.96%)
Short Float %3.56%
Short Ratio4.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)277.53%
Min EPS beat(2)141.26%
Max EPS beat(2)413.81%
EPS beat(4)3
Avg EPS beat(4)183.37%
Min EPS beat(4)-100%
Max EPS beat(4)413.81%
EPS beat(8)4
Avg EPS beat(8)77.5%
EPS beat(12)5
Avg EPS beat(12)8.66%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.87%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)-0.42%
Revenue beat(4)2
Avg Revenue beat(4)1.39%
Min Revenue beat(4)-1.31%
Max Revenue beat(4)4.89%
Revenue beat(8)4
Avg Revenue beat(8)0.68%
Revenue beat(12)6
Avg Revenue beat(12)0.46%
Revenue beat(16)10
Avg Revenue beat(16)0.86%
PT rev (1m)10.3%
PT rev (3m)23.17%
EPS NQ rev (1m)-6.68%
EPS NQ rev (3m)-14.49%
EPS NY rev (1m)34.13%
EPS NY rev (3m)43.4%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.17%
Revenue NY rev (1m)1.15%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 57.6
Fwd PE 52.81
P/S 6.23
P/FCF 49.54
P/OCF 18.55
P/B 7.8
P/tB N/A
EV/EBITDA 16.26
EPS(TTM)0.51
EY1.74%
EPS(NY)0.56
Fwd EY1.89%
FCF(TTM)0.59
FCFY2.02%
OCF(TTM)1.58
OCFY5.39%
SpS4.72
BVpS3.77
TBVpS-3.16
PEG (NY)0.2
PEG (5Y)2.64
Profitability
Industry RankSector Rank
ROA 4.61%
ROE 11.52%
ROCE 6.34%
ROIC 4.66%
ROICexc 5.53%
ROICexgc N/A
OM 10.53%
PM (TTM) 9.2%
GM 73.35%
FCFM 12.57%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
ROICexc(3y)4.06%
ROICexc(5y)5.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.52%
ROCE(5y)4.82%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.36%
ROICexc growth 5Y-3.96%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.1
Cap/Depr 81.27%
Cap/Sales 21%
Interest Coverage 1.54
Cash Conversion 92.3%
Profit Quality 136.62%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 3.99
F-Score6
WACC5.63%
ROIC/WACC0.83
Cap/Depr(3y)86.86%
Cap/Depr(5y)86.55%
Cap/Sales(3y)21.89%
Cap/Sales(5y)22.44%
Profit Quality(3y)195.32%
Profit Quality(5y)194.81%
High Growth Momentum
Growth
EPS 1Y (TTM)230.77%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%3306.25%
EPS Next Y282.53%
EPS Next 2Y106.68%
EPS Next 3Y80.58%
EPS Next 5Y66.45%
Revenue 1Y (TTM)19.38%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%14.14%
Revenue Next Year18.21%
Revenue Next 2Y17.56%
Revenue Next 3Y16.74%
Revenue Next 5Y14.63%
EBIT growth 1Y25.23%
EBIT growth 3Y36.08%
EBIT growth 5Y22.83%
EBIT Next Year117.8%
EBIT Next 3Y53.12%
EBIT Next 5Y38.84%
FCF growth 1Y476.02%
FCF growth 3Y347.38%
FCF growth 5Y21.32%
OCF growth 1Y86.99%
OCF growth 3Y38.73%
OCF growth 5Y19.31%